Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake
Research findings suggest that the dual prevention pill (DPP), an oral contraceptive combined with pre-exposure prophylaxis (PrEP) to prevent HIV in women, may lead to a 2- to 10-fold increase in PrEP use in 15 sub-Saharan countries — a potential market of more than 1 million users. DPP consists of a 28-day dual prevention pill regimen in development by Population Council and currently in Phase 4 Post-marketing Trials.
July 2020
Click for full info +Full Info:
Resource Type:
Citation:
Research findings suggest that the dual prevention pill (DPP), an oral contraceptive combined with PrEP to prevent HIV, may lead to a 2- to 10-fold increase in PrEP use in 15 sub-Saharan countries — a potential market of more than 1 million users
Authors:
Begg L., Brodsky R., Friedland B., Mathur, S., Sailer J., & Creasy G.
Health Risks(s):
- HIV
- Unintended Pregnancy
Product type(s):
- Contraceptives
- Hormonal
- MPTs
Topic(s):
- MPTs
- Development
- Product Introduction
- Trials
Region(s)
- Africa
- Global